The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Support from DFC will help produce one billion vaccine doses by the end of 2022
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
The platform has seen an overall growth of 84% in the number of people seeking consultations for skin-related issues
The first patient dosed with VX-880 demonstrated restoration of insulin production and achieved C-peptide of 560 pmol/L in response to Mixed Meal Tolerance Test (MMTT) at Day 90 visit
Drugs and pharmaceuticals were among the top eight export items in H1FY22, according to a Care Ratings report.
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Subscribe To Our Newsletter & Stay Updated
